You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for Patent: 5,817,028


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,817,028
Title: Method and device for the provocation of air passage narrowing and/or the induction of sputum
Abstract:A method as described for testing the susceptibility of a person to asthma. The person inhales an effective amount of sodium chloride, mannitol or another substance capable of altering the osmolarity of airway surface liquid in the subject. The substance is in the form of a dispersible dry powder containing an effective proportion of particles of a respirable size. The subject is then measured to detect airway narrowing which is indicative of a propensity for asthma. The same technique of dry powder inhalation can be used to test for the susceptibility of a person to rhinitus, to induce sputum and promote mucociliary clearance.
Inventor(s): Anderson; Sandra Doreen (Birchgrove, AU)
Assignee: Central Sydney Area Health Service (Camperdown, AU)
Application Number:08/696,987
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 5,817,028

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,817,028

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPM4114Feb 25, 1994
PCT Information
PCT FiledFebruary 23, 1995PCT Application Number:PCT/AU95/00086
PCT Publication Date:August 31, 1995PCT Publication Number: WO95/22993

International Family Members for US Patent 5,817,028

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0748228 ⤷  Sign Up 11C0002 France ⤷  Sign Up
European Patent Office 0748228 ⤷  Sign Up SPC/GB11/004 United Kingdom ⤷  Sign Up
Austria 474583 ⤷  Sign Up
Australia 1748295 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.